498 related articles for article (PubMed ID: 32554564)
1. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
[TBL] [Abstract][Full Text] [Related]
2. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
[TBL] [Abstract][Full Text] [Related]
3. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
[TBL] [Abstract][Full Text] [Related]
4. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
[TBL] [Abstract][Full Text] [Related]
5. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
[TBL] [Abstract][Full Text] [Related]
6. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
7. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
[TBL] [Abstract][Full Text] [Related]
8. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
[TBL] [Abstract][Full Text] [Related]
9. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
[TBL] [Abstract][Full Text] [Related]
10. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
[TBL] [Abstract][Full Text] [Related]
12. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
Juszczak E; Altman DG; Hopewell S; Schulz K
JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
[TBL] [Abstract][Full Text] [Related]
13. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
[TBL] [Abstract][Full Text] [Related]
14. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
[TBL] [Abstract][Full Text] [Related]
15. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
[TBL] [Abstract][Full Text] [Related]
16. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
J Clin Epidemiol; 2016 May; 73():142-52. PubMed ID: 27101888
[TBL] [Abstract][Full Text] [Related]
17. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
[TBL] [Abstract][Full Text] [Related]
18. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
Junqueira DR; Zorzela L; Golder S; Loke Y; Gagnier JJ; Julious SA; Li T; Mayo-Wilson E; Pham B; Phillips R; Santaguida P; Scherer RW; Gøtzsche PC; Moher D; Ioannidis JPA; Vohra S;
J Clin Epidemiol; 2023 Jun; 158():149-165. PubMed ID: 37100738
[TBL] [Abstract][Full Text] [Related]
19. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
[TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]